Disposable Colonoscope Assists Colorectal Cancer Screening
|
By HospiMedica International staff writers Posted on 14 Dec 2014 |

Image: The Aer-O-Scope Colonoscope System (Photo courtesy of GI View).
An advanced, single use, self-propelled colonoscope offers omnidirectional colorectal cancer (CC) screening.
The Aer-O-Scope System consists of two primary components. The first is the scanning colonoscope component, with a novel optical system that maximizes visualization of the entire colonic mucosa, including behind haustral folds, thanks to advanced optics that enable 360° panoramic visualization, as well as a front view similar to that of conventional colonoscopy. A soft multilumen tube and pneumatic mechanism, directed by pressure measurement control software, makes use of balloons and low pressure CO2 to provide self-propelled intubation and advancement within the colon.
The second component is the Aer-O-Scope work station, which provides the elements to operate the disposable scanner. These include CO2, water, suction and air pressure, and the power supply for the camera and illumination. The work station also receives and processes transmitted data from the camera and scanner. The work station physician interface is equipped with an ergonomic joystick for intuitive control of navigation, insufflation, irrigation, and suction. The Aer-O-Scope Colonoscope System is a product of GI View (Ramat Gan, Israel), and has been approved by the US Food and Drug Administration (FDA).
“Aer-O-Scope is the only colorectal screening product that is single use, self-propelled and has 360° omnidirectional visualization,” said Tal Simchony, MD, CEO of GI-View. “This enables the physician to observe all the mucosa of the colon, including behind folds, which is critical for a complete colonic assessment. If a polyp is there, Aer-O-Scope will allow the physician the best possible chance of finding it.”
Colonoscopy involves the endoscopic examination of the entire large bowel and the distal part of the small bowel via the anus, and has become a primary routine screening test for CC in people who are over 50 years of age. Among people who have had an initial colonoscopy that found no polyps, the risk of developing CC within five years is extremely low, and there is therefore no need for those people to have another colonoscopy sooner than five years after the first screening.
Related Links:
GI View
The Aer-O-Scope System consists of two primary components. The first is the scanning colonoscope component, with a novel optical system that maximizes visualization of the entire colonic mucosa, including behind haustral folds, thanks to advanced optics that enable 360° panoramic visualization, as well as a front view similar to that of conventional colonoscopy. A soft multilumen tube and pneumatic mechanism, directed by pressure measurement control software, makes use of balloons and low pressure CO2 to provide self-propelled intubation and advancement within the colon.
The second component is the Aer-O-Scope work station, which provides the elements to operate the disposable scanner. These include CO2, water, suction and air pressure, and the power supply for the camera and illumination. The work station also receives and processes transmitted data from the camera and scanner. The work station physician interface is equipped with an ergonomic joystick for intuitive control of navigation, insufflation, irrigation, and suction. The Aer-O-Scope Colonoscope System is a product of GI View (Ramat Gan, Israel), and has been approved by the US Food and Drug Administration (FDA).
“Aer-O-Scope is the only colorectal screening product that is single use, self-propelled and has 360° omnidirectional visualization,” said Tal Simchony, MD, CEO of GI-View. “This enables the physician to observe all the mucosa of the colon, including behind folds, which is critical for a complete colonic assessment. If a polyp is there, Aer-O-Scope will allow the physician the best possible chance of finding it.”
Colonoscopy involves the endoscopic examination of the entire large bowel and the distal part of the small bowel via the anus, and has become a primary routine screening test for CC in people who are over 50 years of age. Among people who have had an initial colonoscopy that found no polyps, the risk of developing CC within five years is extremely low, and there is therefore no need for those people to have another colonoscopy sooner than five years after the first screening.
Related Links:
GI View
Latest Surgical Techniques News
- Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
- Novel Glue Prevents Complications After Breast Cancer Surgery
- Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
- Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery
- Revolutionary Nano Bone Material to Accelerate Surgery and Healing
- Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
- Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
- Surgical Treatment of Severe Carotid Artery Stenosis Benefits Blood-Brain Barrier
- Revolutionary Reusable Duodenoscope Introduces 68-Minute Sterilization
- World's First Transcatheter Smart Implant Monitors and Treats Congestion in Heart Failure
- Hybrid Endoscope Marks Breakthrough in Surgical Visualization
- Robot-Assisted Bronchoscope Diagnoses Tiniest and Hardest to Reach Lung Tumors
- Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression
- 3D Printable Bio-Active Glass Could Serve as Bone Replacement Material
- Spider-Inspired Magnetic Soft Robots to Perform Minimally Invasive GI Tract Procedures
- Micro Imaging Device Paired with Endoscope Spots Cancers at Earlier Stage
Channels
Critical Care
view channel
Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
Monitoring blood flow in the brain is crucial for diagnosing and treating neurological conditions such as stroke, traumatic brain injury (TBI), and vascular dementia. However, current imaging methods like... Read more
AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
For decades, doctors have relied on standardized scoring systems to assess patients with the most common type of heart attack—non-ST-elevation acute coronary syndrome (NSTE-ACS). The GRACE score, used... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







